Chison Medical Technologies Co., Ltd. (SHA:688358)
33.68
-1.01 (-2.91%)
May 21, 2026, 3:00 PM CST
SHA:688358 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 120.91 | 116.5 | 140.51 | 146.48 | 105.84 | 112.47 |
Depreciation & Amortization | 13.6 | 13.6 | 14.78 | 14.26 | 13.03 | 9.89 |
Other Amortization | 0.89 | 0.89 | 0.26 | 0.04 | 0.13 | 0.24 |
Loss (Gain) From Sale of Assets | -4.53 | -4.53 | -4.61 | -3.02 | 0.5 | -30.25 |
Asset Writedown & Restructuring Costs | - | - | - | 0.06 | 0.51 | 1.58 |
Loss (Gain) From Sale of Investments | -3.43 | -3.43 | -6.29 | -11.17 | -15 | -17.53 |
Provision & Write-off of Bad Debts | 1.47 | 1.47 | 1.7 | 3.58 | -1.4 | 0.74 |
Other Operating Activities | -26.24 | 16.11 | -16.92 | -19.06 | -15.19 | 6.22 |
Change in Accounts Receivable | -35.68 | -35.68 | -1.01 | -78.87 | 37.02 | -1.55 |
Change in Inventory | -7.03 | -7.03 | 5.65 | 56.08 | -100.41 | -16.76 |
Change in Accounts Payable | 12.05 | 12.05 | 7.83 | -20.33 | 41.92 | -25.33 |
Change in Other Net Operating Assets | -0.06 | -0.06 | -2.03 | -2.92 | -0.82 | 1.37 |
Operating Cash Flow | 69.23 | 107.17 | 140.68 | 85.91 | 63.74 | 39.96 |
Operating Cash Flow Growth | -48.86% | -23.82% | 63.76% | 34.78% | 59.51% | -51.53% |
Capital Expenditures | -15.19 | -14.41 | -8.85 | -34.01 | -52.21 | -39.19 |
Sale of Property, Plant & Equipment | 4.37 | 5.57 | 5.01 | 3.71 | 0.09 | 21.17 |
Investment in Securities | 178.47 | 57.16 | 535.7 | -236.03 | - | 165 |
Other Investing Activities | 8.09 | 9.5 | 23.68 | 25.15 | 6.69 | 17.1 |
Investing Cash Flow | 175.74 | 57.82 | 555.53 | -241.18 | -45.43 | 164.09 |
Long-Term Debt Repaid | - | -4.4 | -4.3 | -0.95 | -0.93 | -0.61 |
Net Debt Issued (Repaid) | -4.4 | -4.4 | -4.3 | -0.95 | -0.93 | -0.61 |
Issuance of Common Stock | 3.74 | 3.74 | - | - | 2.02 | - |
Repurchase of Common Stock | - | - | - | -10.1 | - | - |
Common Dividends Paid | -145.51 | -111.87 | -89.5 | -78.49 | -40 | -64 |
Other Financing Activities | 0.71 | - | - | - | - | - |
Financing Cash Flow | -145.46 | -112.54 | -93.8 | -89.53 | -38.91 | -64.61 |
Foreign Exchange Rate Adjustments | -43.06 | -30.54 | 12.24 | 9.34 | 21.59 | -2.99 |
Net Cash Flow | 56.44 | 21.91 | 614.64 | -235.47 | 0.99 | 136.45 |
Free Cash Flow | 54.04 | 92.76 | 131.83 | 51.9 | 11.53 | 0.78 |
Free Cash Flow Growth | -57.38% | -29.64% | 154.02% | 350.04% | 1386.91% | -98.50% |
Free Cash Flow Margin | 12.41% | 21.29% | 28.13% | 10.73% | 3.03% | 0.19% |
Free Cash Flow Per Share | 0.48 | 0.83 | 1.18 | 0.47 | 0.10 | 0.01 |
Cash Income Tax Paid | - | -7.52 | -2.42 | 0.48 | -6.43 | -14.31 |
Levered Free Cash Flow | -27.58 | 53.66 | 105.05 | -2.85 | -16.31 | 5.74 |
Unlevered Free Cash Flow | -27.39 | 53.86 | 105.28 | -2.63 | -16.24 | 5.78 |
Change in Working Capital | -33.45 | -33.45 | 11.26 | -45.26 | -24.68 | -43.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.